Results 171 to 180 of about 3,493 (205)

Approaches in the Development of the Potentially Pandemic LAIV Candidates

2021
Each year, influenza causes a significant acute respiratory disease burden. In addition, influenza pandemics periodically occur. Vaccination is the best tool for the prevention of both seasonal and pandemic influenza. Currently, three different types of influenza vaccines are available on the market – killed (inactivated), live attenuated (LAIV) and ...
Irina Kiseleva, Natalie Larionova
openaire   +1 more source

Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses [PDF]

Vaccine, 2011
Influenza A infection induces a massive inflammatory response in the lungs that leads to significant illness and increases the susceptibility to secondary bacterial pneumonia. The most efficient way to prevent influenza infection is through vaccination.
Lawrence W Kummer, Stephen T Smiley, Frank M Szaba   +2 more
exaly   +3 more sources

Valorización de Laive S.A.

2021
El presente trabajo tiene como objetivo valorizar la empresa Laive S.A., y hallar el valor fundamental de sus acciones al cierre del 2019. Elegimos a Laive por ser una de las principales empresas del sector lácteos y derivados en el Perú. La compañía inició operaciones hace 109 años, ofreciendo a sus clientes productos lácteos y, posteriormente, agregó
Carranza Ortiz, Valery Marcia, Montalvo Vicente, Betsy Karina, Risco Cordova, Engely Edith   +2 more
openaire   +1 more source

The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study [PDF]

BMC Infectious Diseases, 2014
Rose MA, Damm O, Greiner W, et al. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infectious Diseases.
Martin Eichner, Markus Schwehm, Oliver Damm   +2 more
exaly   +3 more sources

Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment

Pediatrics
CONTEXT The US Advisory Committee on Immunization Practices states a contraindication for live attenuated influenza vaccine (LAIV) use in children aged 2 to 4 years with asthma or recurrent wheeze plus a precaution, defined as defer vaccine use, in those aged & ...
Allyn, Bandell, Lucia, Giles, Penélope, Cervelo Bouzo, Gillian C, Sibbring, Jon, Maniaci, Henry, Wojtczak, Andrew G, Sokolow   +6 more
openaire   +4 more sources

Enlargement of the Parish Church of Laives

2008
The new addition is placed beside the old church on a north-south axis, orthogonal with respect to the direction of the original structure. The new hall is contiguous to an already existing lateral entrance to the old church, to which it is connected by an architectural pause, a glazed buffer that joins the two structures, old and new, while keeping ...
openaire   +1 more source

Efficacy of LAIV-T on Absentee Rates in a School-Based Health Center Sample

Journal of Adolescent Health, 2009
To determine the effectiveness of the intranasal LAIV-T in decreasing school absenteeism in a school-based vaccination initiative and to compare the acceptability of LAIV-T versus TIV among adolescents.This study was conducted within a single, urban community high school in the Fall of 2006.
Cynthia J, Mears, Elisa N, Lawler, Lee D, Sanders, Ben Z, Katz   +3 more
openaire   +2 more sources

Increasing uptake of LAIV in school-based immunisation sessions: A pilot study

British Journal of School Nursing, 2017
Aim: This pilot study aims to evaluate existing innovations, including a poster campaign and uptake data over a small geographic area in order to develop a proposal for practice to increase school-based influenza vaccine uptake levels. Method: Qualitative feedback was gathered via telephone conversation, with uptake data from 2015/16 season and 2016/17
exaly   +2 more sources

Intranasal LAIV preferred for children 2 to 8 years of age

Pharmacy Today, 2014
In late June, CDC's Advisory Committee on Immunization Practice (ACIP) voted unanimously to preferentially recommend the intranasal live attenuated influenza vaccine ([LAIV]; FluMist—AstraZeneca) for use in children aged 2 years to 8 years when product is available.
openaire   +1 more source

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Vaccines, 2023
Honglin Chen, Ivan Fan Ngai Hung
exaly